Znanstveni rad - Izvorni znanstveni rad
LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib
Journal of Cellular and Molecular Medicine, 24 (2020), 5; 2981-2992. https://doi.org/10.1111/jcmm.14930


Citirajte ovaj rad

Markotić, A., Flegar, D., Grčević, D., Šućur, A., Lalić, H., Turčić, P. ... Kelava, T. (2020). LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib. Journal of Cellular and Molecular Medicine, 24. (5), 2981-2992. doi: 10.1111/jcmm.14930

Markotić, Antonio, et al. "LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib." Journal of Cellular and Molecular Medicine, vol. 24, br. 5, 2020, str. 2981-2992. https://doi.org/10.1111/jcmm.14930

Markotić, Antonio, Darja Flegar, Danka Grčević, Alan Šućur, Hrvoje Lalić, Petra Turčić, Nataša Kovačić, et al. "LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib." Journal of Cellular and Molecular Medicine 24, br. 5 (2020): 2981-2992. https://doi.org/10.1111/jcmm.14930

Markotić, A., et al. (2020) 'LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib', Journal of Cellular and Molecular Medicine, 24(5), str. 2981-2992. doi: 10.1111/jcmm.14930

Markotić A, Flegar D, Grčević D, Šućur A, Lalić H, Turčić P, i sur.. LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib. Journal of Cellular and Molecular Medicine [Internet]. 03.2020. [pristupljeno 20.01.2022.];24(5):2981-2992. doi: 10.1111/jcmm.14930

A. Markotić, et al., "LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib", Journal of Cellular and Molecular Medicine, vol. 24, br. 5, str. 2981-2992, Ožujak 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:210422. [Citirano: 20.01.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.